US 11058668 — Patent Expiration

METHODS OF TREATING TTR AMYLOIDOSIS USING AG10

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US11058668

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn more about PTE and patent expiration

US 11058668

Methods Of Treating Ttr Amyloidosis Using Ag10

High Confidence

Application No. 16361587

March 22, 2039

12y 278d remaining

Earliest effective filing

Mar 22, 2019

+ 20 years

Mar 22, 2039

PTA +0d

Mar 22, 2039

No TD

—

Final

Mar 22, 2039

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation Details

Base Term Calculation

Filing Date

March 22, 2019

Earliest Effective Filing

March 22, 2019

Issue Date

July 13, 2021

PTA

0 days

Base Expiry (before PTA)

March 22, 2039

March 22, 2019 + 20 years = March 22, 2039

PRO

62647411 — Provisional — not used for base term

PRO

62765096 — Provisional — not used for base term

PRO

62731629 — Provisional — not used for base term

PRO

62758235 — Provisional — not used for base term

PRO

62810651 — Provisional — not used for base term

Terminal Disclaimer Analysis

No TD

0 approved, 0 filed

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.